These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
97 results:

  • 1. Performance evaluation of predictive models for detecting MMR gene mutations associated with Lynch syndrome in cancer patients in a Chinese cohort in Taiwan.
    Hung FH; Peng HP; Hung CF; Hsieh LL; Yang AS; Wang YA
    Int J Cancer; 2024 Dec; 155(12):2201-2210. PubMed ID: 39032036
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy.
    Giatromanolaki A; Kavazis C; Gkegka AG; Kouroupi M; Tsaroucha A; Pitiakoudis M; Koukourakis MI
    Immunobiology; 2023 Nov; 228(6):152756. PubMed ID: 38860277
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma.
    Gabriel PE; Cancel-Tassin G; Audenet F; Masson-Lecomte A; Allory Y; Roumiguié M; Pradère B; Loriot Y; Léon P; Traxer O; Xylinas E; Rouprêt M; Neuzillet Y; Seisen T
    BJU Int; 2024 Nov; 134(5):723-735. PubMed ID: 38813615
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
    Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
    Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]    [Full Text] [Related]  

  • 6. Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
    Kato MK; Fujii E; Asami Y; Momozawa Y; Hiranuma K; Komatsu M; Hamamoto R; Ebata T; Matsumoto K; Ishikawa M; Kohno T; Kato T; Yoshida H; Shiraishi K
    Cancer Sci; 2024 May; 115(5):1646-1655. PubMed ID: 38433331
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
    Ho YH; Hsu CY; Yau Li AF; Liang WY
    Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
    Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]    [Full Text] [Related]  

  • 10. Mismatch Repair Deficiency in Biliary Tract cancer: Prognostic Implications and Correlation with Histology.
    Vivaldi C; Genovesi V; Ugolini C; Bernardini L; Casadei-Gardini A; Formica V; Salani F; Orsi G; Massa V; Cacciato-Insilla A; Caccese M; Cesario S; Andrikou K; Graziani J; Campani D; Vasile E; Fontanini G; Fornaro L; Masi G
    Oncology; 2024; 102(2):157-167. PubMed ID: 37699372
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types.
    Bartels S; Grote I; Wagner M; Boog J; Schipper E; Reineke-Plaass T; Kreipe H; Lehmann U
    Cancer Med; 2023 Aug; 12(16):16707-16715. PubMed ID: 37376830
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
    Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
    Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon cancers and 5-FU Resistance.
    Cui Z; He S; Wen F; Lu L; Xu L; Wu H; Wu S
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):80. PubMed ID: 37114540
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples.
    Zhang Z; Wan H; Xu B; He H; Shan G; Zhang J; Wu Q; Li T
    Chin Med J (Engl); 2023 May; 136(9):1082-1088. PubMed ID: 37022939
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.
    Kansikas M; Vähätalo L; Kantelinen J; Kasela M; Putula J; Døhlen A; Paloviita P; Kärkkäinen E; Lahti N; Arnez P; Kilpinen S; Alcala-Repo B; Pylvänäinen K; Pöyhönen M; Peltomäki P; Järvinen HJ; Seppälä TT; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Nyström M
    Cancer Res Commun; 2023 Mar; 3(3):361-370. PubMed ID: 36875157
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An exploration of gastric cancer with heterogeneous mismatch repair status.
    Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y
    Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Microsatellite instability in gastric cancer is a predictor of a favorable prognosis].
    Danilova NV; Chayka AV; Khomyakov VM; Oleynikova NA; Andreeva YY; Malkov PG
    Arkh Patol; 2022; 84(6):5-15. PubMed ID: 36469712
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A genetic map of the chromatin regulators to drug response in cancer cells.
    Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
    J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer.
    Kim JH; Kwon BS; Kim H; Suh DH; Kim K; Kim YB; No JH
    Taiwan J Obstet Gynecol; 2022 May; 61(3):415-421. PubMed ID: 35595431
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.